Home Authors Posts by Winway Health Desk

Winway Health Desk

10428 POSTS 0 COMMENTS

Eli Lilly, riding pharma’s rising digital wave, drafts Apple exec to...

Eli Lilly's new digital chief hails from Apple. The latest pharma to tap a consumer executive to head digital strategies, Lilly is swapping CDOs amid an accelerated shift to...

Which medical device companies made the finals for INVEST Pitch Perfect?

The six medical device finalists for the startup pitch contest Pitch Perfect cover surgical retractor systems, catheters, minimally invasive surgery, wireless power transfer technology,...

Federal prosecutors launch Alnylam marketing probe, demanding Onpattro documents

Busy launching several new drugs, RNA biotech Alnylam posted a big revenue increase in 2020—and it expects more growth in 2021, partly thanks to its top-selling Onpattro drug....

Plastic bag shortage a hefty problem for Novavax’s COVID-19 vaccine production...

A shortage of large, sterile plastic bags used to grow vaccine cells has hobbled Novavax's work to scale up its COVID-19 shot production. CEO Stan Erck told...

Cellino Biotech developing tech to help scale stem cell therapies

In response to emailed questions, Cellino Biotech CEO and Co-founder Dr. Nabiha Saklayen, talked about the formation of the company and its goal to...

Resilience keeps expansion spree rolling with buyout of biologics maker Ology

Just six months into its life span, fledgling biomanufacturer National Resilience is moving full speed ahead on its lofty expansion plans. After snaring a...

Cohere Health gains $36M to expand digital prior authorization platform

Cohere Health, a digital health company that provides prior authorization technology, raised $36 million in a Series B financing round. The round, led by Polaris...

3 changes coming to drug pricing

Pounded by both sides of the political aisle, pharmaceutical companies know what it feels like to be whipsawed by opposite ends of the American...

Feds call halt to Johnson & Johnson COVID-19 vaccine rollout after...

After drug regulators on both sides of the Atlantic revealed safety probes into Johnson & Johnson’s COVID-19 vaccine, U.S. officials are calling for an...

Biotech startup Repertoire adds $189M to expand array of immune medicines

  Repertoire Immune Medicines formed last year with research that elucidates the interactions between immune cells and antigens. Though the company’s two most advanced programs...
0FansLike
68,639FollowersFollow
75,100SubscribersSubscribe

EDITOR PICKS